Literature DB >> 28870999

Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature.

Hye Jin Jung1.   

Abstract

Cancer stem cells (CSCs) have been proposed as central drivers of tumor initiation, progression, recurrence, and therapeutic resistance. Therefore, identifying stem-like cells within cancers and understanding their properties is crucial for the development of effective anticancer therapies. Recently, chemical proteomics has become a powerful tool to efficiently determine protein networks responsible for CSC pathophysiology and comprehensively elucidate molecular mechanisms of drug action against CSCs. This review provides an overview of major methodologies utilized in chemical proteomic approaches. In addition, recent successful chemical proteomic applications targeting CSCs are highlighted. Future direction of potential CSC research by integrating chemical genomic and proteomic data obtained from a single biological sample of CSCs are also suggested in this review. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cancer stem cells; chemical proteomics; epithelial to mesenchymal transition; glycoproteomics; phosphoproteomics; review

Mesh:

Substances:

Year:  2017        PMID: 28870999      PMCID: PMC5611518          DOI: 10.21873/cgp.20042

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  105 in total

Review 1.  Glycosylation and the immune system.

Authors:  P M Rudd; T Elliott; P Cresswell; I A Wilson; R A Dwek
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

Review 2.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  The regulation of protein function by multisite phosphorylation--a 25 year update.

Authors:  P Cohen
Journal:  Trends Biochem Sci       Date:  2000-12       Impact factor: 13.807

4.  The origins of protein phosphorylation.

Authors:  Philip Cohen
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

Review 5.  Stem cell factor and chronic myeloid leukemia CD34+ cells.

Authors:  S Moore; L A McDiarmid; T P Hughes
Journal:  Leuk Lymphoma       Date:  2000-07

6.  From genomics to proteomics.

Authors:  Mike Tyers; Matthias Mann
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

7.  Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins.

Authors:  Hiroyuki Kaji; Haruna Saito; Yoshio Yamauchi; Takashi Shinkawa; Masato Taoka; Jun Hirabayashi; Ken-ichi Kasai; Nobuhiro Takahashi; Toshiaki Isobe
Journal:  Nat Biotechnol       Date:  2003-05-18       Impact factor: 54.908

8.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 9.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

10.  Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.

Authors:  Shao-En Ong; Blagoy Blagoev; Irina Kratchmarova; Dan Bach Kristensen; Hanno Steen; Akhilesh Pandey; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2002-05       Impact factor: 5.911

View more
  4 in total

1.  ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance.

Authors:  Dimitrios Tsoumas; Sofia Nikou; Efstathia Giannopoulou; Spyridon Champeris Tsaniras; Chaido Sirinian; Ioannis Maroulis; Stavros Taraviras; Vassiliki Zolota; Haralabos P Kalofonos; Vasiliki Bravou
Journal:  Cancer Genomics Proteomics       Date:  2018 Mar-Apr       Impact factor: 4.069

2.  Prognostic and clinic-pathological significances of HOXB8, ILK and FAT4 expression in colorectal cancer.

Authors:  Abdulwahab A Abuderman; Ola A Harb; Loay M Gertallah
Journal:  Contemp Oncol (Pozn)       Date:  2020-10-30

3.  Cancer stem cells, the ultimate targets in cancer therapy.

Authors:  Ahmed Shabbir; Tuba Esfandyari; Faris Farassati
Journal:  Onco Targets Ther       Date:  2018-01-03       Impact factor: 4.147

4.  Biological Functions and Identification of Novel Biomarker Expressed on the Surface of Breast Cancer-Derived Cancer Stem Cells via Proteomic Analysis.

Authors:  Eun-Young Koh; Ji-Eun You; Se-Hwa Jung; Pyung-Hwan Kim
Journal:  Mol Cells       Date:  2020-04-30       Impact factor: 5.034

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.